NACDS praises ‘swipe fee’ fairness amendment
ALEXANDRIA, Va. The National Association of Chain Drug Stores lauded an amendment that seeks to ensure that interchange “swipe fees” that small businesses and retailers are charged for accepting debit cards are “reasonable and proportional” to the costs incurred by financial entities, the pharmacy group said Monday.
The Restoring American Financial Stability Act of 2010, introduced by Senator Majority Whip Richard J. Durbin, D-Ill., not only will permit retailers the option of offering customer discounts and consumer incentives for those who pay in cash or other debit or credit means, it also will task the Federal Reserve with enhanced regulatory powers over some interchange swipe fees.
NACDS has partnered with other organizations to urge for congressional action on the interchange swipe fee issue.
“On behalf of the NACDS retail members, I want to thank the amendment’s co-sponsors, Senators Durbin, Sanders, Cardin and Specter, for leveling the economic playing field for merchants and consumers,” said NACDS president and CEO Steve Anderson. “This has been a top priority for the retail community for some time, and the Senate’s action is a positive step forward for fairness for consumers and retailers alike.”
Teva receives tentative approval for generic Sensipar
JERUSALEM The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical Industries’ generic version of an Amgen drug, Teva said Friday.
The FDA gave the tentative approval to cincacalcet hydrochloride tablets in the 30-mg, 60-mg and 90-mg strengths. The drug is a generic version of Amgen’s Sensipar, which has annual sales of $458 million, according to IMS Health. The drug is used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.
Tentative approval means that the drug meets most of the conditions for approval, but the FDA cannot grant final approval because the patents covering the drug don’t expire until December 2016, according to FDA records. Teva and Amgen are currently involved in patent litigation concerning the drug in the U.S. District Court for the District of Delaware, though a trial has not been set, Teva said.
RediClinic introduces Teen Health Package
HOUSTON RediClinic is launching in time for summer camp and upcoming school sports a new health package designed specifically for teenagers.
The new Teen Health Package includes a physical exam, an acne consultation and an immunization review for $59.
"We all know that adolescence is a time of great change," stated Susan Cooley King, VP clinical services. "With this in mind, RediClinic created a special health package that addresses the specific health needs of a teen."
Physical exams are always in season. They are required by summer camps and for participation in school sports. During a RedlClinic physical, a clinician evaluates the teen’s medical history. The exam is then performed, checking their physical health including, but not limited to, chest and heart, lymph nodes, blood pressure and abdomen.
Patients of the Teen Health Package also will receive an evaluation of their acne issues and the clinician will make recommendations for the most appropriate treatment ranging from over-the-counter medications to prescriptions.
According to the American Academy of Dermatology, 85% of American teenagers are effected by acne.
Patients also will receive an immunization review whereby the clinician will review the teen’s immunization history, identify which vaccines the patient needs for school admission and administer the vaccines, for an additional charge if necessary.